Furthermore, we ascertain that diminished levels of aPL-IgM, Anti-β2GPI-IgA, and Anti-β2GPI-IgM exhibit a noteworthy association with comorbid hyperlipidemia in stroke patients. The gene discussed is CD40LG; the disease is stroke disorder.